https://en.bioecon.ru/clusters/regenerative-personalized/Recent content in Regenerative-Personalized on BioeconHugoen-USMon, 20 Jul 2026 22:21:00 +0700https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/Electroceutical devices that treat disease by electrically stimulating nerves rather than with drugs — vagus and splenic nerve neuroimmune modulation, AI-personalized spinal cord stimulation, hypoglossal nerve stimulation and implantable neuromodulation for paralysis and neurological disease: SetPoint Medical, Nevro Corp and Inspire Medical Systems in the US, Galvani Bioelectronics and Onward Medical in Europe, and PINS Medical in China.https://en.bioecon.ru/technology/biomimetic-medical-adhesives/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/biomimetic-medical-adhesives/Bio-inspired surgical adhesives, sealants and hemostatic gels that bond, seal or stop bleeding in wet tissue environments where conventional sutures and staples struggle — drawing on biological adhesion mechanisms such as mussel/oyster adhesive proteins: Tissium in France, Cresilon and Brij Medical in the US, and Adhesys Medical in Germany.https://en.bioecon.ru/technology/bionic-prostheses-neuroprosthetics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/bionic-prostheses-neuroprosthetics/Prosthetic devices that replace a lost limb’s function through AI-driven control, touch sensing and direct skeletal attachment — dexterous touch-sensing hands, AI neural prosthetic control, myoelectric pattern recognition and osseointegrated prostheses: Psyonic, Atom Limbs and Coapt in the US, Ottobock and Integrum in Europe, and BrainCo (BrainRobotics) in China.https://en.bioecon.ru/technology/digital-therapeutics/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/digital-therapeutics/Software-as-medical-device treatments that deliver a regulator-cleared clinical intervention rather than general wellness support — prescription digital therapeutics for ADHD, insomnia, anxiety and depression, musculoskeletal digital rehabilitation and pediatric autism intervention: Akili Interactive, Big Health and Click Therapeutics in the US, Kaia Health in Germany, and ALSOLIFE in China.https://en.bioecon.ru/technology/medical-devices-biointerface/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/medical-devices-biointerface/Surface-engineering and coating technologies that govern how a catheter, guidewire, stent or implant actually meets living tissue — hydrophilic lubricious coatings, bioactive anticoagulant polymer layers, and drug-eluting coating systems — spanning Formacoat, Biocoat and Integer Holdings in the US, Freudenberg Medical and DSM Biomedical in Europe, and Sino Medical Sciences Technology in China.https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/partial-epigenetic-reprogramming/Transient expression of Yamanaka reprogramming factors to reverse epigenetic markers of cellular aging without erasing cell identity — OSK gene therapy, AI-discovered reprogramming payloads and safer single-gene rejuvenation targets: Altos Labs, Retro Biosciences, NewLimit and Life Biosciences in the US, Shift Bioscience in the UK, and JingTong Life in China.https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/Mon, 20 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/patient-digital-twins-in-silico-trials/Computational patient models and virtual trial simulations used to reduce, accelerate or de-risk clinical development — AI-generated synthetic control arms, physiologically-based pharmacokinetic modeling, preclinical-to-clinical translation AI and causal-AI virtual patient simulation: Unlearn.AI, Certara and VeriSIM Life in the US, and Novadiscovery (Nova In Silico) in France.https://en.bioecon.ru/technology/consumer-neurotech-wellness-bci-eeg/Sun, 05 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/consumer-neurotech-wellness-bci-eeg/Dry-electrode EEG wearables — headbands, earbuds and sleep masks — that read brainwave activity without gel or clinical setup, using on-device AI artifact removal and neurofeedback training to support meditation, focus and sleep, regulated as general wellness devices rather than medical BCI.https://en.bioecon.ru/technology/exosome-therapy-extracellular-vesicles/Sat, 04 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/exosome-therapy-extracellular-vesicles/Cell-derived nanoscale vesicles (30-150 nm) used as native regenerative-medicine agents or engineered as biocompatible drug-delivery vehicles for RNA, protein and gene-editing cargo, crossing biological barriers artificial lipid nanoparticles cannot.https://en.bioecon.ru/technology/geroscience-senolytics/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/geroscience-senolytics/Selectively clearing senescent ‘zombie’ cells or suppressing their inflammatory secretome to treat age-related disease at its molecular root, rather than one downstream condition at a time.https://en.bioecon.ru/technology/in-vitro-gametogenesis-reproductive-synbio/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/in-vitro-gametogenesis-reproductive-synbio/Deriving functional human eggs and sperm entirely outside the body from reprogrammed stem cells, aimed at reversing absolute infertility and enabling genome-corrected embryos.https://en.bioecon.ru/technology/xenotransplantation/Fri, 03 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/xenotransplantation/Transplanting organs from multiplex gene-edited pigs into humans to address the chronic shortage of donor organs, now moving from expanded-access compassionate cases into FDA-cleared clinical trials.https://en.bioecon.ru/technology/biomedical-engineering-implants/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/biomedical-engineering-implants/The engineering of medical devices that interface with the body — orthopedic, cardiovascular and neuro implants — sold as capital robotic systems, per-procedure implants and regulated biomaterials under FDA, EU MDR and NMPA oversight.https://en.bioecon.ru/technology/femtech-biotech-womens-health/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/femtech-biotech-womens-health/Specialized biologic, diagnostic and live-biotherapeutic products for conditions that affect exclusively or disproportionately women — non-invasive endometriosis testing, ovarian-longevity therapeutics, vaginal-microbiome LBPs and cfDNA prenatal screening, under FDA, EU IVDR/EMA and NMPA oversight.https://en.bioecon.ru/technology/neurointerfaces-bci/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/neurointerfaces-bci/Brain–computer interfaces that read motor and speech cortex activity and decode intent into text, synthesized voice or robotic movement — spanning invasive intracortical arrays, endovascular stent-electrodes, semi-invasive ECoG and non-invasive EEG, under FDA IDE trials, EU MDR and NMPA oversight.https://en.bioecon.ru/technology/personalized-nutrition/Fri, 26 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/personalized-nutrition/Dietary recommendations tailored to an individual’s gut microbiome, DNA and real-time glucose response, delivered as test-kit subscriptions, AI food scores and custom-formulated supplements.https://en.bioecon.ru/technology/organ-tissue-bioprinting/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/organ-tissue-bioprinting/Additive manufacturing of living cells and biomaterials to construct functional tissue models and transplantable organs.https://en.bioecon.ru/technology/personalized-regenerative-medicine/Fri, 19 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/personalized-regenerative-medicine/Gene and cell therapy platforms for rare monogenic and oncological diseases: AAV vectors, lentiviral HSC editing, ex vivo CRISPR (Casgevy) and in vivo CRISPR (LNP delivery) now deliver durable one-time treatments approved by FDA and EMA.